Recent clinical findings have shown that the suppression of VEGF-A to subnormal levels results in proteinuria, hypertension and renal thrombotic microangiopathy (Feliu et al., 2015; Lafayette et al., 2014). This evidence concerns the gene VEGFA and Hypertension.